BIOMAT Database Logo BIOMAT Database Logo

Plasma factor triggering alternative complement pathway activation by liposomes. 1994

K Funato, and C Yamashita, and J Kamada, and S Tominaga, and H Kiwada
Faculty of Pharmaceutical Sciences, University of Tokushima, Japan.

Several plasma components, such as complement (C) components, play a role in the clearance of liposomes from the circulation. The interactions between liposomes and the C system were investigated in this study. Multilamellar vesicle (MLV) liposomes, which were damaged by activation of the complement, became susceptible depending on the density of cetylmannoside (Man) on the liposome membrane, and activation proceeded through the alternative C pathway as observed for liposomes without Man (PC-MLV) (K. Funato et al., Biochim. Biophys. Acta 1103:198-204, 1992). In addition, the capacity of Man-modified liposomes (Man-MLV) to activate the alternative C pathway was abolished by preadsorption of plasma with Man-MLV but not with PC-MLV. The results suggest that a specific plasma factor adsorbed with Man-MLV was responsible for the augmentation of the C activation and, further, that the rapid clearance of Man-MLV from the circulation is caused by both enhanced C-mediated liposome permeability and enhanced C-mediated phagocytosis of liposomes.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008297 Male Males
D008362 Mannosides Glycosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of mannose with an alcohol to form an acetal. They include both alpha- and beta-mannosides. Mannoside
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D003170 Complement Pathway, Alternative Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE (C3BBB) which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE (C3BBB3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Alternative Complement Pathway,Properdin Pathway,Alternative Complement Activation Pathway,Complement Activation Pathway, Alternative
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

K Funato, and C Yamashita, and J Kamada, and S Tominaga, and H Kiwada
Activation of human complement by liposomes: serum factor requirement for alternative pathway activation.
August 1980, Journal of immunology (Baltimore, Md. : 1950),
K Funato, and C Yamashita, and J Kamada, and S Tominaga, and H Kiwada
Membrane sialoglycolipids regulate the activation of alternative complement pathway by liposomes containing trinitrophenylaminocaproyldipalmitoylphosphatidylethaolamine.
January 1983, Immunology,
K Funato, and C Yamashita, and J Kamada, and S Tominaga, and H Kiwada
Activation of human complement by liposomes: a model for membrane activation of the alternative pathway.
April 1979, Journal of immunology (Baltimore, Md. : 1950),
K Funato, and C Yamashita, and J Kamada, and S Tominaga, and H Kiwada
Studies on the mechanism of PMN activation. II. By triggering the alternative pathway of complement activation.
July 1982, Blut,
K Funato, and C Yamashita, and J Kamada, and S Tominaga, and H Kiwada
Alternative pathway for complement activation triggered by human liver plasma membranes.
August 1981, Hepato-gastroenterology,
K Funato, and C Yamashita, and J Kamada, and S Tominaga, and H Kiwada
Characterization of bovine serum factor triggering the lysis of liposomes via complement activation.
April 1998, Biological & pharmaceutical bulletin,
K Funato, and C Yamashita, and J Kamada, and S Tominaga, and H Kiwada
Inhibiting alternative pathway complement activation by targeting the factor D exosite.
April 2012, The Journal of biological chemistry,
K Funato, and C Yamashita, and J Kamada, and S Tominaga, and H Kiwada
Activation of the alternative complement pathway of guinea-gip by liposomes incorporated with trinitrophenylated phosphatidylethanolamine.
January 1982, Immunology,
K Funato, and C Yamashita, and J Kamada, and S Tominaga, and H Kiwada
Effect of cetylmannoside modification on the alternative complement pathway activation by liposomes in rat serum.
April 1995, Biological & pharmaceutical bulletin,
K Funato, and C Yamashita, and J Kamada, and S Tominaga, and H Kiwada
Alternative complement pathway activation by C4b deposited during classical pathway activation.
April 1986, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!